Assays of fibrin network properties altered by VKAs in atrial fibrillation – importance of using an appropriate coagulation trigger

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Thrombosis and Haemostasis

• Publication date

  2014-12-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH14-07-0591PMID 25518887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrin clot properties and their modulation in thrombotic disorders

  2014cited by this paper
• Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates

  2013influential reference
• An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values

  2012cited by this paper
• Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate *

  2011cited by this paper
• Guidelines on oral anticoagulation with warfarin – fourth edition

  2011cited by this paper
• Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.

  2011influential reference
• Thrombin generation tests.

  2011cited by this paper
• Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke.

  2011cited by this paper
• The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis

  2010influential reference
• Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.

  2010cited by this paper
• Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.

  2009cited by this paper
• Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation

  2008cited by this paper
• Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Atrial fibrillation and stroke prevention.

  2007cited by this paper
• Marked increase of fibrin gel permeability with very low dose ASA treatment.

  2005cited by this paper
• Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials

  2005cited by this paper
• Calibrated Automated Thrombin Generation Measurement in Clotting Plasma

  2003cited by this paper
• Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

  2003cited by this paper
• Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.

  2001cited by this paper
• Biochemistry and Physiology of Blood Coagulation

  1999cited by this paper
• Warfarin or Acenocoumarol: Which Is better in the Management of Oral Anticoagulants?

  1998cited by this paper
• Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

  1993cited by this paper
• Fibrin gel structure and clotting time.

  1982cited by this paper
• British Committee for Standards in Haematology

  1969cited by this paper

• Potential for application of direct thrombin inhibitors isolated from Euphorbia resinifera O.Berg latex in fibrin clot formation.

  2025cites this paper
• Prevalence of Left Atrial Thrombus in Patients with Atrial Flutter in Comparison to Atrial Fibrillation.

  2025cites this paper
• Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis

  2024cites this paper
• Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease

  2023cites this paper
• Improving the antithrombogenicity of nylon monofilament for surgical suture by coating a protease from Euphorbia resinifera latex

  2022cites this paper
• Changes in fibrinolytic activity and coagulation factors after epicardial left atrial appendage closure in patients with atrial fibrillation

  2022cites this paper
• Fibrin Network Porosity and Endo-/Exogenous Thrombin Cross-talk

  2021cites this paper
• Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolism.

  2020cites this paper
• Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors

  2020cites this paper
• The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review

  2020cites this paper
• Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P‐selectin predict occult cancer after unprovoked venous thromboembolism

  2019cites this paper
• A Prothrombotic State in Patients With a History of Left Ventricular Thrombus.

  2019cites this paper
• Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism

  2018cites this paper
• Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study.

  2018cites this paper
• Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillation

  2018cites this paper
• An increased tendency in fibrinogen activity and its association with a hypo-fibrinolytic state in early stages after injury in patients without acute traumatic coagulopathy (ATC)

  2018cites this paper
• Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants.

  2018cites this paper
• Impaired fibrinolysis in degenerative mitral and aortic valve stenosis

  2018cites this paper
• Growth of Epithelial Organoids in a Defined Hydrogel

  2018cites this paper
• A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples).

  2018cites this paper
• Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism

  2018cites this paper
• Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.

  2017cites this paper
• Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence

  2017cites this paper
• Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin

  2016cites this paper
• Clot structure and fibrinolytic potential in patients with post thrombotic syndrome.

  2016cites this paper
• Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function

  2016cites this paper
• How to Assess Fibrinogen Levels and Fibrin Clot Properties in Clinical Practice?

  2016cites this paper
• Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.

  2015cites this paper
• Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3days of treatment: Relation to coagulation factors and thrombin generation.

  2015cites this paper
• Worsening renal function

  2013cites this paper